Man Group »

Crispr Therapeutics shares owned by Man Group

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Man Group from 13F filings

Historical chart of Man Group investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Man Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.5M 110k 68.16
2023-12-31 $15M 236k 62.60
2023-09-30 $8.1M 178k 45.39
2023-06-30 $7.4M 132k 56.14
2022-06-30 $3.4M 56k 61.40
2022-03-31 $3.9M 62k 62.78
2021-09-30 $2.8M 25k 111.92
2021-03-31 $221k 1.8k 121.83
2020-12-31 $3.8M 25k 153.15
2020-09-30 $979k 12k 83.63
2020-06-30 $6.3M 85k 73.44
2020-03-31 $435k 10k 42.65
2019-12-31 $2.8M 46k 60.89
2019-03-31 $1.8M 51k 35.71
2018-09-30 $392k 8.8k 44.44